0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Muscle Pain Relief Patches Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-6F17019
Home | Market Reports | Health| Health Conditions| Pain Management
Global Muscle Pain Relief Patches Market Research Report 2024
BUY CHAPTERS

Global Muscle Pain Relief Patches Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-6F17019
Report
November 2025
Pages:198
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Muscle Pain Relief Patches Market

The global Muscle Pain Relief Patches market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
From a downstream perspective, Hospital accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Muscle Pain Relief Patches leading manufacturers including Hisamitsu, Mylan, Johnson & Johnson, Teva, Lingrui, Sanofi, Qizheng, Endo, Huarun 999, GSK, etc., dominate supply; the top five capture approximately % of global revenue, with Hisamitsu leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Muscle Pain Relief Patches market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Muscle Pain Relief Patches Market Report

Report Metric Details
Report Name Muscle Pain Relief Patches Market
Segment by Type
  • OTC
  • Rx
Segment by Application
  • Hospital
  • Drug Store
  • Online Supermarket
  • Others
Production by Region
  • North America
  • Europe
  • China
  • Japan
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Hisamitsu, Mylan, Johnson & Johnson, Teva, Lingrui, Sanofi, Qizheng, Endo, Huarun 999, GSK, Haw Par, Nichiban, Laboratoires Genevrier, BLUE-EMU, IBSA Group, Pfizer, Performance Health, Actavis, Teikoku Seiyaku, Novartis, Mentholatum Company, China Resources Sanjiu Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Muscle Pain Relief Patches study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.
  • Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.
  • Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Muscle Pain Relief Patches Market report?

Ans: The main players in the Muscle Pain Relief Patches Market are Hisamitsu, Mylan, Johnson & Johnson, Teva, Lingrui, Sanofi, Qizheng, Endo, Huarun 999, GSK, Haw Par, Nichiban, Laboratoires Genevrier, BLUE-EMU, IBSA Group, Pfizer, Performance Health, Actavis, Teikoku Seiyaku, Novartis, Mentholatum Company, China Resources Sanjiu Pharmaceutical

What are the Application segmentation covered in the Muscle Pain Relief Patches Market report?

Ans: The Applications covered in the Muscle Pain Relief Patches Market report are Hospital, Drug Store, Online Supermarket, Others

What are the Type segmentation covered in the Muscle Pain Relief Patches Market report?

Ans: The Types covered in the Muscle Pain Relief Patches Market report are OTC, Rx

1 Study Coverage
1.1 Introduction to Muscle Pain Relief Patches: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Muscle Pain Relief Patches Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 OTC
1.2.3 Rx
1.3 Market Segmentation by Application
1.3.1 Global Muscle Pain Relief Patches Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Drug Store
1.3.4 Online Supermarket
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Muscle Pain Relief Patches Revenue Estimates and Forecasts 2020-2031
2.2 Global Muscle Pain Relief Patches Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Muscle Pain Relief Patches Sales Estimates and Forecasts 2020-2031
2.4 Global Muscle Pain Relief Patches Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Global Production Analysis
3.1 Global Muscle Pain Relief Patches Production Capacity and Utilization Rates (2020–2031)
3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)
3.3 Regional Production Dynamics
3.3.1 Historic Production by Region (2020-2025)
3.3.2 Forecasted Production by Region (2026-2031)
3.3.3 Production Market Share by Region (2020-2031)
3.3.4 Regulatory and Trade Policy Impact on Production
3.3.5 Production Capacity Enablers and Constraints
3.4 Key Regional Production Hubs
3.4.1 North America
3.4.2 Europe
3.4.3 China
3.4.4 Japan
4 Competition by Manufacturers
4.1 Global Muscle Pain Relief Patches Sales by Manufacturers
4.1.1 Global Sales Volume by Manufacturers (2020-2025)
4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
4.2 Global Muscle Pain Relief Patches Manufacturer Revenue Rankings and Tiers
4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
4.3 Manufacturer Profitability Profiles and Pricing Strategies
4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
4.3.2 Manufacturer-Level Price Trends (2020-2025)
4.4 Key Manufacturers Manufacturing Base and Headquarters
4.5 Main Product Type Market Size by Manufacturers
4.5.1 OTC Market Size by Manufacturers
4.5.2 Rx Market Size by Manufacturers
4.6 Global Muscle Pain Relief Patches Market Concentration and Dynamics
4.6.1 Global Market Concentration (CR5 and HHI)
4.6.2 Entrant/Exit Impact Analysis
4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
5 Global Product Segmentation Analysis
5.1 Global Muscle Pain Relief Patches Sales Performance by Type
5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
5.1.2 Global Sales Market Share by Type (2020-2031)
5.2 Global Muscle Pain Relief Patches Revenue Trends by Type
5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
5.2.2 Global Revenue Market Share by Type (2020-2031)
5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
5.4 Product Technology Differentiation
5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
5.5.1 High-Growth Niches and Adoption Drivers
5.5.2 Profitability Hotspots and Cost Drivers
5.5.3 Substitution Threats
6 Global Downstream Application Analysis
6.1 Global Muscle Pain Relief Patches Sales by Application
6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
6.1.2 Global Sales Market Share by Application (2020-2031)
6.1.3 High-Growth Application Identification
6.1.4 Emerging Application Case Studies
6.2 Global Muscle Pain Relief Patches Revenue by Application
6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
6.2.2 Revenue Market Share by Application (2020-2031)
6.3 Global Pricing Dynamics by Application (2020-2031)
6.4 Downstream Customer Analysis
6.4.1 Top Customers by Region
6.4.2 Top Customers by Application
7 North America
7.1 North America Sales Volume and Revenue (2020-2031)
7.2 North America Key Manufacturers Sales Revenue in 2024
7.3 North America Muscle Pain Relief Patches Sales and Revenue by Type (2020-2031)
7.4 North America Muscle Pain Relief Patches Sales and Revenue by Application (2020-2031)
7.5 North America Growth Accelerators and Market Barriers
7.6 North America Muscle Pain Relief Patches Market Size by Country
7.6.1 North America Revenue by Country
7.6.2 North America Sales Trends by Country
7.6.3 US
7.6.4 Canada
7.6.5 Mexico
8 Europe
8.1 Europe Sales Volume and Revenue (2020-2031)
8.2 Europe Key Manufacturers Sales Revenue in 2024
8.3 Europe Muscle Pain Relief Patches Sales and Revenue by Type (2020-2031)
8.4 Europe Muscle Pain Relief Patches Sales and Revenue by Application (2020-2031)
8.5 Europe Growth Accelerators and Market Barriers
8.6 Europe Muscle Pain Relief Patches Market Size by Country
8.6.1 Europe Revenue by Country
8.6.2 Europe Sales Trends by Country
8.6.3 Germany
8.6.4 France
8.6.5 U.K.
8.6.6 Italy
8.6.7 Russia
9 Asia-Pacific
9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
9.3 Asia-Pacific Muscle Pain Relief Patches Sales and Revenue by Type (2020-2031)
9.4 Asia-Pacific Muscle Pain Relief Patches Sales and Revenue by Application (2020-2031)
9.5 Asia-Pacific Muscle Pain Relief Patches Market Size by Region
9.5.1 Asia-Pacific Revenue by Region
9.5.2 Asia-Pacific Sales Trends by Region
9.6 Asia-Pacific Growth Accelerators and Market Barriers
9.7 Southeast Asia
9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand
9.8 China
9.9 Japan
9.10 South Korea
9.11 China Taiwan
9.12 India
10 Central and South America
10.1 Central and South America Sales Volume and Revenue (2020-2031)
10.2 Central and South America Key Manufacturers Sales Revenue in 2024
10.3 Central and South America Muscle Pain Relief Patches Sales and Revenue by Type (2020-2031)
10.4 Central and South America Muscle Pain Relief Patches Sales and Revenue by Application (2020-2031)
10.5 Central and South America Investment Opportunities and Key Challenges
10.6 Central and South America Muscle Pain Relief Patches Market Size by Country
10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 Brazil
10.6.3 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
11.3 Middle East and Africa Muscle Pain Relief Patches Sales and Revenue by Type (2020-2031)
11.4 Middle East and Africa Muscle Pain Relief Patches Sales and Revenue by Application (2020-2031)
11.5 Middle East and Africa Investment Opportunities and Key Challenges
11.6 Middle East and Africa Muscle Pain Relief Patches Market Size by Country
11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
11.6.2 GCC Countries
11.6.3 Turkey
11.6.4 Egypt
11.6.5 South Africa
12 Corporate Profile
12.1 Hisamitsu
12.1.1 Hisamitsu Corporation Information
12.1.2 Hisamitsu Business Overview
12.1.3 Hisamitsu Muscle Pain Relief Patches Product Models, Descriptions and Specifications
12.1.4 Hisamitsu Muscle Pain Relief Patches Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.1.5 Hisamitsu Muscle Pain Relief Patches Sales by Product in 2024
12.1.6 Hisamitsu Muscle Pain Relief Patches Sales by Application in 2024
12.1.7 Hisamitsu Muscle Pain Relief Patches Sales by Geographic Area in 2024
12.1.8 Hisamitsu Muscle Pain Relief Patches SWOT Analysis
12.1.9 Hisamitsu Recent Developments
12.2 Mylan
12.2.1 Mylan Corporation Information
12.2.2 Mylan Business Overview
12.2.3 Mylan Muscle Pain Relief Patches Product Models, Descriptions and Specifications
12.2.4 Mylan Muscle Pain Relief Patches Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.2.5 Mylan Muscle Pain Relief Patches Sales by Product in 2024
12.2.6 Mylan Muscle Pain Relief Patches Sales by Application in 2024
12.2.7 Mylan Muscle Pain Relief Patches Sales by Geographic Area in 2024
12.2.8 Mylan Muscle Pain Relief Patches SWOT Analysis
12.2.9 Mylan Recent Developments
12.3 Johnson & Johnson
12.3.1 Johnson & Johnson Corporation Information
12.3.2 Johnson & Johnson Business Overview
12.3.3 Johnson & Johnson Muscle Pain Relief Patches Product Models, Descriptions and Specifications
12.3.4 Johnson & Johnson Muscle Pain Relief Patches Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.3.5 Johnson & Johnson Muscle Pain Relief Patches Sales by Product in 2024
12.3.6 Johnson & Johnson Muscle Pain Relief Patches Sales by Application in 2024
12.3.7 Johnson & Johnson Muscle Pain Relief Patches Sales by Geographic Area in 2024
12.3.8 Johnson & Johnson Muscle Pain Relief Patches SWOT Analysis
12.3.9 Johnson & Johnson Recent Developments
12.4 Teva
12.4.1 Teva Corporation Information
12.4.2 Teva Business Overview
12.4.3 Teva Muscle Pain Relief Patches Product Models, Descriptions and Specifications
12.4.4 Teva Muscle Pain Relief Patches Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.4.5 Teva Muscle Pain Relief Patches Sales by Product in 2024
12.4.6 Teva Muscle Pain Relief Patches Sales by Application in 2024
12.4.7 Teva Muscle Pain Relief Patches Sales by Geographic Area in 2024
12.4.8 Teva Muscle Pain Relief Patches SWOT Analysis
12.4.9 Teva Recent Developments
12.5 Lingrui
12.5.1 Lingrui Corporation Information
12.5.2 Lingrui Business Overview
12.5.3 Lingrui Muscle Pain Relief Patches Product Models, Descriptions and Specifications
12.5.4 Lingrui Muscle Pain Relief Patches Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.5.5 Lingrui Muscle Pain Relief Patches Sales by Product in 2024
12.5.6 Lingrui Muscle Pain Relief Patches Sales by Application in 2024
12.5.7 Lingrui Muscle Pain Relief Patches Sales by Geographic Area in 2024
12.5.8 Lingrui Muscle Pain Relief Patches SWOT Analysis
12.5.9 Lingrui Recent Developments
12.6 Sanofi
12.6.1 Sanofi Corporation Information
12.6.2 Sanofi Business Overview
12.6.3 Sanofi Muscle Pain Relief Patches Product Models, Descriptions and Specifications
12.6.4 Sanofi Muscle Pain Relief Patches Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.6.5 Sanofi Recent Developments
12.7 Qizheng
12.7.1 Qizheng Corporation Information
12.7.2 Qizheng Business Overview
12.7.3 Qizheng Muscle Pain Relief Patches Product Models, Descriptions and Specifications
12.7.4 Qizheng Muscle Pain Relief Patches Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.7.5 Qizheng Recent Developments
12.8 Endo
12.8.1 Endo Corporation Information
12.8.2 Endo Business Overview
12.8.3 Endo Muscle Pain Relief Patches Product Models, Descriptions and Specifications
12.8.4 Endo Muscle Pain Relief Patches Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.8.5 Endo Recent Developments
12.9 Huarun 999
12.9.1 Huarun 999 Corporation Information
12.9.2 Huarun 999 Business Overview
12.9.3 Huarun 999 Muscle Pain Relief Patches Product Models, Descriptions and Specifications
12.9.4 Huarun 999 Muscle Pain Relief Patches Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.9.5 Huarun 999 Recent Developments
12.10 GSK
12.10.1 GSK Corporation Information
12.10.2 GSK Business Overview
12.10.3 GSK Muscle Pain Relief Patches Product Models, Descriptions and Specifications
12.10.4 GSK Muscle Pain Relief Patches Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.10.5 GSK Recent Developments
12.11 Haw Par
12.11.1 Haw Par Corporation Information
12.11.2 Haw Par Business Overview
12.11.3 Haw Par Muscle Pain Relief Patches Product Models, Descriptions and Specifications
12.11.4 Haw Par Muscle Pain Relief Patches Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.11.5 Haw Par Recent Developments
12.12 Nichiban
12.12.1 Nichiban Corporation Information
12.12.2 Nichiban Business Overview
12.12.3 Nichiban Muscle Pain Relief Patches Product Models, Descriptions and Specifications
12.12.4 Nichiban Muscle Pain Relief Patches Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.12.5 Nichiban Recent Developments
12.13 Laboratoires Genevrier
12.13.1 Laboratoires Genevrier Corporation Information
12.13.2 Laboratoires Genevrier Business Overview
12.13.3 Laboratoires Genevrier Muscle Pain Relief Patches Product Models, Descriptions and Specifications
12.13.4 Laboratoires Genevrier Muscle Pain Relief Patches Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.13.5 Laboratoires Genevrier Recent Developments
12.14 BLUE-EMU
12.14.1 BLUE-EMU Corporation Information
12.14.2 BLUE-EMU Business Overview
12.14.3 BLUE-EMU Muscle Pain Relief Patches Product Models, Descriptions and Specifications
12.14.4 BLUE-EMU Muscle Pain Relief Patches Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.14.5 BLUE-EMU Recent Developments
12.15 IBSA Group
12.15.1 IBSA Group Corporation Information
12.15.2 IBSA Group Business Overview
12.15.3 IBSA Group Muscle Pain Relief Patches Product Models, Descriptions and Specifications
12.15.4 IBSA Group Muscle Pain Relief Patches Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.15.5 IBSA Group Recent Developments
12.16 Pfizer
12.16.1 Pfizer Corporation Information
12.16.2 Pfizer Business Overview
12.16.3 Pfizer Muscle Pain Relief Patches Product Models, Descriptions and Specifications
12.16.4 Pfizer Muscle Pain Relief Patches Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.16.5 Pfizer Recent Developments
12.17 Performance Health
12.17.1 Performance Health Corporation Information
12.17.2 Performance Health Business Overview
12.17.3 Performance Health Muscle Pain Relief Patches Product Models, Descriptions and Specifications
12.17.4 Performance Health Muscle Pain Relief Patches Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.17.5 Performance Health Recent Developments
12.18 Actavis
12.18.1 Actavis Corporation Information
12.18.2 Actavis Business Overview
12.18.3 Actavis Muscle Pain Relief Patches Product Models, Descriptions and Specifications
12.18.4 Actavis Muscle Pain Relief Patches Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.18.5 Actavis Recent Developments
12.19 Teikoku Seiyaku
12.19.1 Teikoku Seiyaku Corporation Information
12.19.2 Teikoku Seiyaku Business Overview
12.19.3 Teikoku Seiyaku Muscle Pain Relief Patches Product Models, Descriptions and Specifications
12.19.4 Teikoku Seiyaku Muscle Pain Relief Patches Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.19.5 Teikoku Seiyaku Recent Developments
12.20 Novartis
12.20.1 Novartis Corporation Information
12.20.2 Novartis Business Overview
12.20.3 Novartis Muscle Pain Relief Patches Product Models, Descriptions and Specifications
12.20.4 Novartis Muscle Pain Relief Patches Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.20.5 Novartis Recent Developments
12.21 Mentholatum Company
12.21.1 Mentholatum Company Corporation Information
12.21.2 Mentholatum Company Business Overview
12.21.3 Mentholatum Company Muscle Pain Relief Patches Product Models, Descriptions and Specifications
12.21.4 Mentholatum Company Muscle Pain Relief Patches Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.21.5 Mentholatum Company Recent Developments
12.22 China Resources Sanjiu Pharmaceutical
12.22.1 China Resources Sanjiu Pharmaceutical Corporation Information
12.22.2 China Resources Sanjiu Pharmaceutical Business Overview
12.22.3 China Resources Sanjiu Pharmaceutical Muscle Pain Relief Patches Product Models, Descriptions and Specifications
12.22.4 China Resources Sanjiu Pharmaceutical Muscle Pain Relief Patches Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.22.5 China Resources Sanjiu Pharmaceutical Recent Developments
13 Value Chain and Supply-Chain Analysis
13.1 Muscle Pain Relief Patches Industry Chain
13.2 Muscle Pain Relief Patches Upstream Materials Analysis
13.2.1 Raw Materials
13.2.2 Key Suppliers Market Share & Risk Assessment
13.3 Muscle Pain Relief Patches Integrated Production Analysis
13.3.1 Manufacturing Footprint Analysis
13.3.2 Production Technology Overview
13.3.3 Regional Cost Drivers
13.4 Muscle Pain Relief Patches Sales Channels and Distribution Networks
13.4.1 Sales Channels
13.4.2 Distributors
14 Muscle Pain Relief Patches Market Dynamics
14.1 Industry Trends and Evolution
14.2 Market Growth Drivers and Emerging Opportunities
14.3 Market Challenges, Risks, and Restraints
15 Key Findings in the Global Muscle Pain Relief Patches Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.1.1 Research Programs/Design
16.1.1.2 Market Size Estimation
16.1.1.3 Market Breakdown and Data Triangulation
16.1.2 Data Source
16.1.2.1 Secondary Sources
16.1.2.2 Primary Sources
16.2 Author Details
List of Tables
 Table 1. Global Muscle Pain Relief Patches Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Muscle Pain Relief Patches Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Muscle Pain Relief Patches Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Muscle Pain Relief Patches Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Muscle Pain Relief Patches Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Muscle Pain Relief Patches Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 7. Global Muscle Pain Relief Patches Sales by Region (2020-2025) & (Tons)
 Table 8. Global Muscle Pain Relief Patches Sales by Region (2026-2031) & (Tons)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Muscle Pain Relief Patches Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 11. Global Muscle Pain Relief Patches Production by Region (2020-2025) & (Tons)
 Table 12. Global Muscle Pain Relief Patches Production by Region (2026-2031) & (Tons)
 Table 13. Global Muscle Pain Relief Patches Sales by Manufacturers (2020-2025) & (Tons)
 Table 14. Global Muscle Pain Relief Patches Sales Share by Manufacturers (2020-2025)
 Table 15. Global Muscle Pain Relief Patches Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 16. Global Muscle Pain Relief Patches Revenue Market Share by Manufacturers (2020-2025)
 Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 18. Global Muscle Pain Relief Patches by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Muscle Pain Relief Patches as of 2024)
 Table 19. Global Muscle Pain Relief Patches Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 20. Global Muscle Pain Relief Patches Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Ton)
 Table 21. Key Manufacturers Muscle Pain Relief Patches Manufacturing Base and Headquarters
 Table 22. Global Muscle Pain Relief Patches Market Concentration Ratio (CR5 and HHI)
 Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 25. Global Muscle Pain Relief Patches Sales by Type (2020-2025) & (Tons)
 Table 26. Global Muscle Pain Relief Patches Sales by Type (2026-2031) & (Tons)
 Table 27. Global Muscle Pain Relief Patches Revenue by Type (2020-2025) & (US$ Million)
 Table 28. Global Muscle Pain Relief Patches Revenue by Type (2026-2031) & (US$ Million)
 Table 29. Global Muscle Pain Relief Patches ASP by Type (2020-2031) & (US$/Ton)
 Table 30. Technical Specifications by Key Product Type
 Table 31. Global Muscle Pain Relief Patches Sales by Application (2020-2025) & (Tons)
 Table 32. Global Muscle Pain Relief Patches Sales by Application (2026-2031) & (Tons)
 Table 33. Muscle Pain Relief Patches High-Growth Sectors Demand CAGR (2024-2031)
 Table 34. Global Muscle Pain Relief Patches Revenue by Application (2020-2025) & (US$ Million)
 Table 35. Global Muscle Pain Relief Patches Revenue by Application (2026-2031) & (US$ Million)
 Table 36. Global Muscle Pain Relief Patches ASP by Application (2020-2031) & (US$/Ton)
 Table 37. Top Customers by Region
 Table 38. Top Customers by Application
 Table 39. North America Muscle Pain Relief Patches Growth Accelerators and Market Barriers
 Table 40. North America Muscle Pain Relief Patches Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 41. North America Muscle Pain Relief Patches Sales (Tons) by Country (2020 VS 2024 VS 2031)
 Table 42. Europe Muscle Pain Relief Patches Growth Accelerators and Market Barriers
 Table 43. Europe Muscle Pain Relief Patches Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 44. Europe Muscle Pain Relief Patches Sales (Tons) by Country (2020 VS 2024 VS 2031)
 Table 45. Asia-Pacific Muscle Pain Relief Patches Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Asia-Pacific Muscle Pain Relief Patches Sales (Tons) by Country (2020 VS 2024 VS 2031)
 Table 47. Asia-Pacific Muscle Pain Relief Patches Growth Accelerators and Market Barriers
 Table 48. Southeast Asia Muscle Pain Relief Patches Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 49. Central and South America Muscle Pain Relief Patches Investment Opportunities and Key Challenges
 Table 50. Central and South America Muscle Pain Relief Patches Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 51. Middle East and Africa Muscle Pain Relief Patches Investment Opportunities and Key Challenges
 Table 52. Middle East and Africa Muscle Pain Relief Patches Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 53. Hisamitsu Corporation Information
 Table 54. Hisamitsu Description and Major Businesses
 Table 55. Hisamitsu Product Models, Descriptions and Specifications
 Table 56. Hisamitsu Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 57. Hisamitsu Sales Value Proportion by Product in 2024
 Table 58. Hisamitsu Sales Value Proportion by Application in 2024
 Table 59. Hisamitsu Sales Value Proportion by Geographic Area in 2024
 Table 60. Hisamitsu Muscle Pain Relief Patches SWOT Analysis
 Table 61. Hisamitsu Recent Developments
 Table 62. Mylan Corporation Information
 Table 63. Mylan Description and Major Businesses
 Table 64. Mylan Product Models, Descriptions and Specifications
 Table 65. Mylan Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 66. Mylan Sales Value Proportion by Product in 2024
 Table 67. Mylan Sales Value Proportion by Application in 2024
 Table 68. Mylan Sales Value Proportion by Geographic Area in 2024
 Table 69. Mylan Muscle Pain Relief Patches SWOT Analysis
 Table 70. Mylan Recent Developments
 Table 71. Johnson & Johnson Corporation Information
 Table 72. Johnson & Johnson Description and Major Businesses
 Table 73. Johnson & Johnson Product Models, Descriptions and Specifications
 Table 74. Johnson & Johnson Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 75. Johnson & Johnson Sales Value Proportion by Product in 2024
 Table 76. Johnson & Johnson Sales Value Proportion by Application in 2024
 Table 77. Johnson & Johnson Sales Value Proportion by Geographic Area in 2024
 Table 78. Johnson & Johnson Muscle Pain Relief Patches SWOT Analysis
 Table 79. Johnson & Johnson Recent Developments
 Table 80. Teva Corporation Information
 Table 81. Teva Description and Major Businesses
 Table 82. Teva Product Models, Descriptions and Specifications
 Table 83. Teva Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 84. Teva Sales Value Proportion by Product in 2024
 Table 85. Teva Sales Value Proportion by Application in 2024
 Table 86. Teva Sales Value Proportion by Geographic Area in 2024
 Table 87. Teva Muscle Pain Relief Patches SWOT Analysis
 Table 88. Teva Recent Developments
 Table 89. Lingrui Corporation Information
 Table 90. Lingrui Description and Major Businesses
 Table 91. Lingrui Product Models, Descriptions and Specifications
 Table 92. Lingrui Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 93. Lingrui Sales Value Proportion by Product in 2024
 Table 94. Lingrui Sales Value Proportion by Application in 2024
 Table 95. Lingrui Sales Value Proportion by Geographic Area in 2024
 Table 96. Lingrui Muscle Pain Relief Patches SWOT Analysis
 Table 97. Lingrui Recent Developments
 Table 98. Sanofi Corporation Information
 Table 99. Sanofi Description and Major Businesses
 Table 100. Sanofi Product Models, Descriptions and Specifications
 Table 101. Sanofi Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 102. Sanofi Recent Developments
 Table 103. Qizheng Corporation Information
 Table 104. Qizheng Description and Major Businesses
 Table 105. Qizheng Product Models, Descriptions and Specifications
 Table 106. Qizheng Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 107. Qizheng Recent Developments
 Table 108. Endo Corporation Information
 Table 109. Endo Description and Major Businesses
 Table 110. Endo Product Models, Descriptions and Specifications
 Table 111. Endo Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 112. Endo Recent Developments
 Table 113. Huarun 999 Corporation Information
 Table 114. Huarun 999 Description and Major Businesses
 Table 115. Huarun 999 Product Models, Descriptions and Specifications
 Table 116. Huarun 999 Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 117. Huarun 999 Recent Developments
 Table 118. GSK Corporation Information
 Table 119. GSK Description and Major Businesses
 Table 120. GSK Product Models, Descriptions and Specifications
 Table 121. GSK Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 122. GSK Recent Developments
 Table 123. Haw Par Corporation Information
 Table 124. Haw Par Description and Major Businesses
 Table 125. Haw Par Product Models, Descriptions and Specifications
 Table 126. Haw Par Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 127. Haw Par Recent Developments
 Table 128. Nichiban Corporation Information
 Table 129. Nichiban Description and Major Businesses
 Table 130. Nichiban Product Models, Descriptions and Specifications
 Table 131. Nichiban Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 132. Nichiban Recent Developments
 Table 133. Laboratoires Genevrier Corporation Information
 Table 134. Laboratoires Genevrier Description and Major Businesses
 Table 135. Laboratoires Genevrier Product Models, Descriptions and Specifications
 Table 136. Laboratoires Genevrier Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 137. Laboratoires Genevrier Recent Developments
 Table 138. BLUE-EMU Corporation Information
 Table 139. BLUE-EMU Description and Major Businesses
 Table 140. BLUE-EMU Product Models, Descriptions and Specifications
 Table 141. BLUE-EMU Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 142. BLUE-EMU Recent Developments
 Table 143. IBSA Group Corporation Information
 Table 144. IBSA Group Description and Major Businesses
 Table 145. IBSA Group Product Models, Descriptions and Specifications
 Table 146. IBSA Group Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 147. IBSA Group Recent Developments
 Table 148. Pfizer Corporation Information
 Table 149. Pfizer Description and Major Businesses
 Table 150. Pfizer Product Models, Descriptions and Specifications
 Table 151. Pfizer Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 152. Pfizer Recent Developments
 Table 153. Performance Health Corporation Information
 Table 154. Performance Health Description and Major Businesses
 Table 155. Performance Health Product Models, Descriptions and Specifications
 Table 156. Performance Health Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 157. Performance Health Recent Developments
 Table 158. Actavis Corporation Information
 Table 159. Actavis Description and Major Businesses
 Table 160. Actavis Product Models, Descriptions and Specifications
 Table 161. Actavis Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 162. Actavis Recent Developments
 Table 163. Teikoku Seiyaku Corporation Information
 Table 164. Teikoku Seiyaku Description and Major Businesses
 Table 165. Teikoku Seiyaku Product Models, Descriptions and Specifications
 Table 166. Teikoku Seiyaku Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 167. Teikoku Seiyaku Recent Developments
 Table 168. Novartis Corporation Information
 Table 169. Novartis Description and Major Businesses
 Table 170. Novartis Product Models, Descriptions and Specifications
 Table 171. Novartis Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 172. Novartis Recent Developments
 Table 173. Mentholatum Company Corporation Information
 Table 174. Mentholatum Company Description and Major Businesses
 Table 175. Mentholatum Company Product Models, Descriptions and Specifications
 Table 176. Mentholatum Company Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 177. Mentholatum Company Recent Developments
 Table 178. China Resources Sanjiu Pharmaceutical Corporation Information
 Table 179. China Resources Sanjiu Pharmaceutical Description and Major Businesses
 Table 180. China Resources Sanjiu Pharmaceutical Product Models, Descriptions and Specifications
 Table 181. China Resources Sanjiu Pharmaceutical Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 182. China Resources Sanjiu Pharmaceutical Recent Developments
 Table 183. Key Raw Materials Distribution
 Table 184. Raw Materials Key Suppliers
 Table 185. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 186. Milestones in Production Technology Evolution
 Table 187. Distributors List
 Table 188. Market Trends and Market Evolution
 Table 189. Market Drivers and Opportunities
 Table 190. Market Challenges, Risks, and Restraints
 Table 191. Research Programs/Design for This Report
 Table 192. Key Data Information from Secondary Sources
 Table 193. Key Data Information from Primary Sources


List of Figures
 Figure 1. Muscle Pain Relief Patches Product Picture
 Figure 2. Global Muscle Pain Relief Patches Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. OTC Product Picture
 Figure 4. Rx Product Picture
 Figure 5. Global Muscle Pain Relief Patches Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. Hospital
 Figure 7. Drug Store
 Figure 8. Online Supermarket
 Figure 9. Others
 Figure 10. Muscle Pain Relief Patches Report Years Considered
 Figure 11. Global Muscle Pain Relief Patches Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Muscle Pain Relief Patches Revenue (2020-2031) & (US$ Million)
 Figure 13. Global Muscle Pain Relief Patches Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 14. Global Muscle Pain Relief Patches Revenue Market Share by Region (2020-2031)
 Figure 15. Global Muscle Pain Relief Patches Sales (2020-2031) & (Tons)
 Figure 16. Global Muscle Pain Relief Patches Sales (CAGR) by Region (2020-2031) (Tons)
 Figure 17. Global Muscle Pain Relief Patches Sales Market Share by Region (2020-2031)
 Figure 18. Global Muscle Pain Relief Patches Capacity, Production and Utilization (2020-2031) & (Tons)
 Figure 19. Global Muscle Pain Relief Patches Production Trend by Region (2020-2031) (Tons)
 Figure 20. Global Muscle Pain Relief Patches Production Market Share by Region (2020-2031)
 Figure 21. Production Capacity Enablers & Constraints
 Figure 22. Muscle Pain Relief Patches Production Growth Rate in North America (2020-2031) & (Tons)
 Figure 23. Muscle Pain Relief Patches Production Growth Rate in Europe (2020-2031) & (Tons)
 Figure 24. Muscle Pain Relief Patches Production Growth Rate in China (2020-2031) & (Tons)
 Figure 25. Muscle Pain Relief Patches Production Growth Rate in Japan (2020-2031) & (Tons)
 Figure 26. Top 5 and Top 10 Manufacturers Muscle Pain Relief Patches Sales Volume Market Share in 2024
 Figure 27. Global Muscle Pain Relief Patches Revenue Market Share Ranking (2024)
 Figure 28. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 29. OTC Revenue Market Share by Manufacturer in 2024
 Figure 30. Rx Revenue Market Share by Manufacturer in 2024
 Figure 31. Type Eight Revenue Market Share by Manufacturer in 2024
 Figure 32. Type Nine Revenue Market Share by Manufacturer in 2024
 Figure 33. Global Muscle Pain Relief Patches Sales Market Share by Type (2020-2031)
 Figure 34. Global Muscle Pain Relief Patches Revenue Market Share by Type (2020-2031)
 Figure 35. Global Muscle Pain Relief Patches Sales Market Share by Application (2020-2031)
 Figure 36. Global Muscle Pain Relief Patches Revenue Market Share by Application (2020-2031)
 Figure 37. North America Muscle Pain Relief Patches Sales YoY (2020-2031) & (Tons)
 Figure 38. North America Muscle Pain Relief Patches Revenue YoY (2020-2031) & (US$ Million)
 Figure 39. North America Top 5 Manufacturers Muscle Pain Relief Patches Sales Revenue (US$ Million) in 2024
 Figure 40. North America Muscle Pain Relief Patches Sales Volume (Tons) by Type (2020- 2031)
 Figure 41. North America Muscle Pain Relief Patches Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 42. North America Muscle Pain Relief Patches Sales Volume (Tons) by Application (2020-2031)
 Figure 43. North America Muscle Pain Relief Patches Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 44. US Muscle Pain Relief Patches Revenue (2020-2031) & (US$ Million)
 Figure 45. Canada Muscle Pain Relief Patches Revenue (2020-2031) & (US$ Million)
 Figure 46. Mexico Muscle Pain Relief Patches Revenue (2020-2031) & (US$ Million)
 Figure 47. Europe Muscle Pain Relief Patches Sales YoY (2020-2031) & (Tons)
 Figure 48. Europe Muscle Pain Relief Patches Revenue YoY (2020-2031) & (US$ Million)
 Figure 49. Europe Top 5 Manufacturers Muscle Pain Relief Patches Sales Revenue (US$ Million) in 2024
 Figure 50. Europe Muscle Pain Relief Patches Sales Volume (Tons) by Type (2020-2031)
 Figure 51. Europe Muscle Pain Relief Patches Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 52. Europe Muscle Pain Relief Patches Sales Volume (Tons) by Application (2020-2031)
 Figure 53. Europe Muscle Pain Relief Patches Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 54. Germany Muscle Pain Relief Patches Revenue (2020-2031) & (US$ Million)
 Figure 55. France Muscle Pain Relief Patches Revenue (2020-2031) & (US$ Million)
 Figure 56. U.K. Muscle Pain Relief Patches Revenue (2020-2031) & (US$ Million)
 Figure 57. Italy Muscle Pain Relief Patches Revenue (2020-2031) & (US$ Million)
 Figure 58. Russia Muscle Pain Relief Patches Revenue (2020-2031) & (US$ Million)
 Figure 59. Asia-Pacific Muscle Pain Relief Patches Sales YoY (2020-2031) & (Tons)
 Figure 60. Asia-Pacific Muscle Pain Relief Patches Revenue YoY (2020-2031) & (US$ Million)
 Figure 61. Asia-Pacific Top 8 Manufacturers Muscle Pain Relief Patches Sales Revenue (US$ Million) in 2024
 Figure 62. Asia-Pacific Muscle Pain Relief Patches Sales Volume (Tons) by Type (2020- 2031)
 Figure 63. Asia-Pacific Muscle Pain Relief Patches Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 64. Asia-Pacific Muscle Pain Relief Patches Sales Volume (Tons) by Application (2020-2031)
 Figure 65. Asia-Pacific Muscle Pain Relief Patches Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 66. Indonesia Muscle Pain Relief Patches Revenue (2020-2031) & (US$ Million)
 Figure 67. Japan Muscle Pain Relief Patches Revenue (2020-2031) & (US$ Million)
 Figure 68. South Korea Muscle Pain Relief Patches Revenue (2020-2031) & (US$ Million)
 Figure 69. China Taiwan Muscle Pain Relief Patches Revenue (2020-2031) & (US$ Million)
 Figure 70. India Muscle Pain Relief Patches Revenue (2020-2031) & (US$ Million)
 Figure 71. Central and South America Muscle Pain Relief Patches Sales YoY (2020-2031) & (Tons)
 Figure 72. Central and South America Muscle Pain Relief Patches Revenue YoY (2020-2031) & (US$ Million)
 Figure 73. Central and South America Top 5 Manufacturers Muscle Pain Relief Patches Sales Revenue (US$ Million) in 2024
 Figure 74. Central and South America Muscle Pain Relief Patches Sales Volume (Tons) by Type (2021-2031)
 Figure 75. Central and South America Muscle Pain Relief Patches Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 76. Central and South America Muscle Pain Relief Patches Sales Volume (Tons) by Application (2020-2031)
 Figure 77. Central and South America Muscle Pain Relief Patches Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 78. Brazil Muscle Pain Relief Patches Revenue (2020-2025) & (US$ Million)
 Figure 79. Argentina Muscle Pain Relief Patches Revenue (2020-2025) & (US$ Million)
 Figure 80. Middle East, and Africa Muscle Pain Relief Patches Sales YoY (2020-2031) & (Tons)
 Figure 81. Middle East and Africa Muscle Pain Relief Patches Revenue YoY (2020-2031) & (US$ Million)
 Figure 82. Middle East and Africa Top 5 Manufacturers Muscle Pain Relief Patches Sales Revenue (US$ Million) in 2024
 Figure 83. Middle East and Africa Muscle Pain Relief Patches Sales Volume (Tons) by Type (2021-2031)
 Figure 84. South America Muscle Pain Relief Patches Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 85. Middle East and Africa Muscle Pain Relief Patches Sales Volume (Tons) by Application (2020-2031)
 Figure 86. Middle East and Africa Muscle Pain Relief Patches Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 87. GCC Countries Muscle Pain Relief Patches Revenue (2020-2025) & (US$ Million)
 Figure 88. Turkey Muscle Pain Relief Patches Revenue (2020-2025) & (US$ Million)
 Figure 89. Egypt Muscle Pain Relief Patches Revenue (2020-2025) & (US$ Million)
 Figure 90. South Africa Muscle Pain Relief Patches Revenue (2020-2025) & (US$ Million)
 Figure 91. Muscle Pain Relief Patches Industry Chain Mapping
 Figure 92. Regional Muscle Pain Relief Patches Manufacturing Base Distribution (%)
 Figure 93. Muscle Pain Relief Patches Production Process
 Figure 94. Regional Muscle Pain Relief Patches Production Cost Structure
 Figure 95. Channels of Distribution (Direct Vs Distribution)
 Figure 96. Bottom-up and Top-down Approaches for This Report
 Figure 97. Data Triangulation
 Figure 98. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

RELATED REPORTS

Global Muscle Pain Relief Patches Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-6F17019
Fri Nov 14 00:00:00 UTC 2025

Add to Cart

Add to Cart

Global Pain Relief Gel Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-35S16884
Thu Nov 06 00:00:00 UTC 2025

Add to Cart

Global Locoplex Plexus and Peripheral Nerve Block Needle Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-25Q17042
Tue Nov 04 00:00:00 UTC 2025

Add to Cart